Anti PD-L1 (Atezolizumab) as an Immune Primer and Concurrently with Extended Field Chemoradiotherapy for Node Positive Locally Advanced Cervical Cancer.

BACKGROUND: There is a lack of data exploring the use and optimal timing of immunotherapy and chemoradiation (CRT) in node positive cervical cancer. Further translational research into mechanisms of response and resistance to immunotherapy in advanced cervical cancer is warranted. Primary Objective(...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Gynecol Cancer
Main Authors: Mayadev, Jyoti, Zamarin, Dmitriy, Deng, Wei, Lankes, Heather, O’Cearbhaill, Roisin, Aghajanian, Carol A, Schilder, Russell
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7310564/
https://ncbi.nlm.nih.gov/pubmed/31871115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ijgc-2019-001012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados